Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6415)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2013 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Curtin BF, Zarbalian Y, Flasar MH, Rosenvinge EV. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i46/8647.htm |
| Number | Citing Articles |
| 1 |
Gregory R Madden, Kyle B Enfield, Costi D Sifri. Patient Outcomes With Prevented vs Negative Clostridioides difficile Tests Using a Computerized Clinical Decision Support Tool. Open Forum Infectious Diseases 2020; 7(4) doi: 10.1093/ofid/ofaa094
|
| 2 |
Csaba Fehér, Josep Mensa. A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management. Infectious Diseases and Therapy 2016; 5(3): 207 doi: 10.1007/s40121-016-0122-1
|
| 3 |
Shannon A. Novosad, Yi Mu, Lisa G. Winston, Helen Johnston, Elizabeth Basiliere, Danyel M. Olson, Monica M. Farley, Andrew Revis, Lucy Wilson, Rebecca Perlmutter, Stacy M. Holzbauer, Tory Whitten, Erin C. Phipps, Ghinwa K. Dumyati, Zintars G. Beldavs, Valerie L. S. Ocampo, Corinne M. Davis, Marion Kainer, Dale N. Gerding, Alice Y. Guh. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013–2015. Journal of General Internal Medicine 2020; 35(2): 412 doi: 10.1007/s11606-019-05386-9
|
| 4 |
H. Benoist, A. de La Blanchardière, A. Flatres, C. Isnard, P. Thibon, G. Saint-Lorant. Effect of a prospective audit with intervention and feedback on Clostridioides difficile infection management. International Journal of Clinical Pharmacy 2020; 42(3): 923 doi: 10.1007/s11096-020-01050-z
|
| 5 |
I. N. Zakharova, I. V. Berezhnaya, E. B. Mumladze. Antibiotic-associated diarrhea in children: how to identify, what to do and how to treat?. Medical Council 2016; 1(1): 78 doi: 10.21518/2079-701X-2016-1-78-89
|
| 6 |
Shelley C. Moore. Clostridium difficile. Critical Care Nursing Clinics of North America 2018; 30(1): 41 doi: 10.1016/j.cnc.2017.10.004
|
| 7 |
Mazen S. Bader, John Hawboldt, Cheryl Main, Dominik Mertz, Mark Loeb, Alison Farrell, Joanna Joyce. Review of high dose vancomycin in the treatment of Clostridioides difficile infection. Infectious Diseases 2020; 52(12): 847 doi: 10.1080/23744235.2020.1800080
|
| 8 |
Ali Elbeddini, Rachel Gerochi. Treatment of Clostridium difficile infection in community teaching hospital: a retrospective study. Journal of Pharmaceutical Policy and Practice 2021; 14(1) doi: 10.1186/s40545-020-00289-1
|
| 9 |
Julie Auclair, Martin Frappier, Mathieu Millette. Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridium difficile Infection. Clinical Infectious Diseases 2015; 60(suppl_2): S135 doi: 10.1093/cid/civ179
|
| 10 |
K. Kobayashi, N. Sekiya, Y. Ainoda, H. Kurai, A. Imamura. Adherence to clinical practice guidelines for the management of Clostridium difficile infection in Japan: a multicenter retrospective study. European Journal of Clinical Microbiology & Infectious Diseases 2017; 36(10): 1947 doi: 10.1007/s10096-017-3018-4
|
| 11 |
I. Patel, M. Wungjiranirun, T. Theethira, J. Villafuerte-Galvez, N. Castillo, M. Akbari, C. D. Alonso, D. A. Leffler, C. P. Kelly.
Lack of adherence to SHEA-IDSA treatment guidelines for
Clostridium difficile
infection is associated with increased mortality
. Journal of Antimicrobial Chemotherapy 2017; 72(2): 574 doi: 10.1093/jac/dkw423
|
| 12 |
K. T. CROWELL, K. G. JULIAN, M. KATZMAN, A. S. BERG, A. TINSLEY, E. D. WILLIAMS, W. A. KOLTUN, E. MESSARIS. Compliance with Clostridium difficile treatment guidelines: effect on patient outcomes. Epidemiology and Infection 2017; 145(11): 2185 doi: 10.1017/S0950268817000644
|
| 13 |
Gregory R. Madden, Melinda D. Poulter, Costi D. Sifri. Diagnostic stewardship and the 2017 update of the IDSA-SHEA Clinical Practice Guidelines for Clostridium difficile Infection. Diagnosis 2018; 5(3): 119 doi: 10.1515/dx-2018-0012
|
| 14 |
Johnny Zakhour, Sara F Haddad, Anthony Kerbage, Heiman Wertheim, Pierre Tattevin, Andreas Voss, Serhat Ünal, Abdoul Salam Ouedraogo, Souha S Kanj. Diagnostic stewardship in infectious diseases: a continuum of antimicrobial stewardship in the fight against antimicrobial resistance. International Journal of Antimicrobial Agents 2023; 62(1): 106816 doi: 10.1016/j.ijantimicag.2023.106816
|
| 15 |
C. Rodríguez-Martín, A. Serrano-Morte, L.A. Sánchez-Muñoz, P.A. de Santos-Castro, M.A. Bratos-Pérez, R. Ortiz de Lejarazu-Leonardo. Diferencias entre las recomendaciones y la práctica clínica en la infección por Clostridium difficile. Revista de Calidad Asistencial 2016; 31(3): 152 doi: 10.1016/j.cali.2015.09.009
|